These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8037206)

  • 41. Novel mutation in an Egyptian patient with infantile Canavan disease.
    Zaki OK; El Abd HS; Mohamed SA; Zayed H
    Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A benign polymorphism in the aspartoacylase gene may cause misinterpretation of Canavan gene testing.
    Propheta O; Magal N; Shohat M; Eyal N; Navot N; Horowitz M
    Eur J Hum Genet; 1998; 6(6):635-7. PubMed ID: 9887384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
    Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
    Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
    ACOG Committee on Genetics
    Obstet Gynecol; 2004 Aug; 104(2):425-8. PubMed ID: 15292027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
    Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
    Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in Canavan disease.
    Matalon R; Michals-Matalon K
    Adv Pediatr; 1999; 46():493-506. PubMed ID: 10645473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
    Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
    Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystic fibrosis in Jews: frequency and mutation distribution.
    Kerem B; Chiba-Falek O; Kerem E
    Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews.
    Lehavi O; Aizenstein O; Bercovich D; Pavzner D; Shomrat R; Orr-Urtreger A; Yaron Y
    Genet Test; 2003; 7(2):139-42. PubMed ID: 12885336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspartoacylase gene knockout in the mouse: impact on reproduction.
    Surendran S; Szucs S; Tyring SK; Matalon R
    Reprod Toxicol; 2005; 20(2):281-3. PubMed ID: 15907664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
    Edelmann L; Dong J; Desnick RJ; Kornreich R
    Am J Hum Genet; 2002 Apr; 70(4):1023-7. PubMed ID: 11845410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.
    Verlander PC; Kaporis A; Liu Q; Zhang Q; Seligsohn U; Auerbach AD
    Blood; 1995 Dec; 86(11):4034-8. PubMed ID: 7492758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.
    Whitney MA; Saito H; Jakobs PM; Gibson RA; Moses RE; Grompe M
    Nat Genet; 1993 Jun; 4(2):202-5. PubMed ID: 8348157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing.
    Schuchman EH; Miranda SR
    Genet Test; 1997; 1(1):13-9. PubMed ID: 10464620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L; Stackievitz R; Shpitz B; Yarkoni S
    Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state.
    Kogan A; Shinar Y; Lidar M; Revivo A; Langevitz P; Padeh S; Pras M; Livneh A
    Am J Med Genet; 2001 Aug; 102(3):272-6. PubMed ID: 11484206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
    Quintana-Murci L; Gal I; Bakhan T; Quach H; Sayar SH; Shiri-Sverdlov R; Baruch RG; McElreavey K; Dagan E; Narod S; Friedman E
    Fam Cancer; 2005; 4(2):85-8. PubMed ID: 15951957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.